Cardiovascular risk and sub-clinical atherosclerosis in prostate cancer: patient with and without androgen ablation.

M. Overman, C. Wang, R. Detrano, M. Douglas-Escobar, E. Ipp, B. Hara, E. Layos, R. Swerdloff, N. Berman, R. Chlebowski